Hot Products

Isoelemicin
Catalog No: CFN97886

Reference standards.

Isoengeletin
Catalog No: CFN95284

Isoescin IA
Catalog No: CFN90932

Escin Ia and Isoescin IA have been traditionally used clinically as the chief active ingredients of escin, a major triterpene saponin isolated from horse chestnut (Aesculus hippocastanum) seeds for the treatment of chronic venous insufficiency, hemorrhoids, inflammation and edema.

Isoescin IB
Catalog No: CFN90933

Isoescin IB is a natural product from Aesculus hippocastanum L.

Isoeuphorbetin
Catalog No: CFN95207

Reference standards.

Isofebrifugine
Catalog No: CFN92303

Isofebrifugine shows antimalarial activity.

Isoferulic acid
Catalog No: CFN98282

Isoferulic acid is an effective natural antioxidant in both lipid and aqueous media, it may be a new promising anti-glycation agent for the prevention of diabetic complications via inhibition of advanced glycation end products (AGEs) formation and oxidation-dependent protein damage. Isoferulic acid is a novel and potent inhibitor of murine IL-8 production, it also has inhibitory effect on mushroom tyrosinase.

Isoformononetin
Catalog No: CFN95024

Isoformononetin shows fungitoxic activity against Cladosporium sphaerospermum; it also has immunomodulatory activity, it inhibits the differentiation of Th17 cells and B-cell lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions. Isoformononetin reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.

Isoforsythiaside
Catalog No: CFN98591

Isoforsythiaside has antioxidant, and antibacterial activities.

Isofraxidin
Catalog No: CFN90181

Isofraxidin has definite anti-bacterial, anti-oxidant, analgesic,and anti-inflammatory activities, it inhibits expression of MMP-7 and in vitro cell invasion at a non-toxic level through inhibiting ERK1/2 phosphorylation in hepatoma cell lines.Isofraxidin is one possible radio-protector, it can protect leukemia cells from radiation-induced apoptosis via ROS/mitochondria pathway in a p53-independent manner.